Evidence-based regenerative and functional medicine

We read the research.
You make better decisions.

Stem cells, peptides, NAD+, HBOT, and the functional medicine everyone is arguing about. 480+ guides built from peer-reviewed studies, written for patients and practitioners who want the mechanism, the evidence, the real cost, and the risk. Not the marketing.

Browse all guides How we review content

No clinic, supplement brand, or telehealth company pays us for a kinder verdict.

A researcher at a lab bench reading a printed study in morning light beside a microscope

480+ Research-backed guides, one editorial standard

Cited Journal, authors, year, and sample size on the claims that matter

Graded A plain evidence rating at the top of every treatment page

$0 Taken from clinics, brands, or telehealth for a kinder verdict

The standard we hold every guide to

Named sources, not vague claims

We cite the journal, the authors, the year, and the sample size. If a claim rests on a single mouse study, we say so on the page, in the same sentence.

Evidence grading on every treatment

Each therapy opens with a plain rating for how strong the human evidence actually is, from well-established to experimental, before any of the hope.

Honest about what does not work

We publish the disappointing trials too. No clinic, supplement brand, or telehealth company can buy a warmer verdict, because none of them pay us.

The guides people read first

Start where the questions are loudest. Each guide walks through how the treatment works, who it actually helps, what it realistically costs, and where the evidence is still thin.

Macro close-up of clear therapy vials on a neutral surface with shallow focus

PROMISING

Peptide Therapy

BPC-157, TB-500, and the rest: what has real human data, what is still animal work, and what the compounding rules changed in 2024.

A person sitting calmly by a window at home in soft daylight holding a mug

Start with your body, not the buzzword

If you came here because of a diagnosis that took years to get a name, or because you were told there was nothing there, begin here. We map the treatments being tried for each condition and grade the evidence behind each one, so you can tell a real option from a hopeful one.

Or start with a treatment you are weighing

Considering a specific therapy? Read the mechanism, the human trials, the realistic cost, and the safety profile before you sit in a consult or spend a dollar.

Top-down close-up of an open journal page with highlighted lines and a pen resting on it

How we grade the evidence

Every treatment page opens with a grade, before the hope. The grade is never a traffic light. There is no red, amber, or green doing quiet marketing work. It is one evergreen mark that fills further as the human evidence gets stronger, so it reads the same whether or not you see color.

WELL-ESTABLISHED Large, repeated human trials agree.
PROMISING Early human data looks good but is not settled.
EXPERIMENTAL Mostly lab or animal work so far.
NOT SUPPORTED The studies were done and it did not hold up.

See our full review process

Built for two hard jobs

For patients

You should not be reading trial abstracts at 2am

You already do the work no one asked you to do: cross-checking a forum claim against a study you half understand, alone, when you should be asleep. We do that reading in daylight and hand you the part that changes your decision, in plain language, with the source attached.

For practitioners

Built to survive a second opinion

Print any guide and it holds up when your patient Googles it in the parking lot, and when a colleague pushes back. We link the primary literature, note the sample sizes, and flag where a claim outruns its evidence, so you can hand it over without a caveat.

What we will tell you that a clinic won’t

We take no money from clinics, supplement brands, or telehealth companies, which is why we can write the sentence they cannot. That a popular peptide has almost no human data. That an expensive infusion is unlikely to touch your condition. That the trial everyone quotes had nineteen people in it. Being useful sometimes means being the ones who disappoint you, and we would rather you learn it here than after the invoice.

Updates

One email when the evidence actually changes

No weekly filler and no drip campaign. Once or twice a month at most, and only when a real trial lands, a guide gets a new grade, or we have to walk back something we published.

No data selling. Unsubscribe in one click.

480+ guides. One standard. No agenda.

Read the research without reading every study yourself. Start with the guide for your condition or the treatment you are weighing, and see exactly where the evidence stands today.